Document Detail


Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancer.
MedLine Citation:
PMID:  12109515     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The aim of this study was to improve the diagnostic efficiency of tumor markers in the diagnosis of lung cancer, by the mathematical evaluation of a tumor marker profile employing fuzzy logic modelling.
METHODS: A panel of four tumor markers, i.e., carcinoembryonic antigen (CEA), cytokeratin 19 antibody (CYFRA 21-1), neuron-specific enolase (NSE), squamous cell carcinoma-related antigen (SCC) and, additionally, C-reactive protein (CRP), was measured in 175 newly diagnosed lung cancer patients with different histological types and stages. Results were compared with those in 120 control subjects, including 27 with chronic obstructive pulmonary diseases (COPD), 65 with pneumoconiosis, and 11 persons with acute inflammatory lung diseases. A classificator was developed using a fuzzy-logic rule-based system.
RESULTS: Application of the fuzzy-logic rule-based system to the tumor marker values of CYFRA 21-1, NSE, and CRP yielded an increase in sensitivity of approximately 20%, i.e., 92%, compared with that of the best single marker, CYFRA 21-1(sensitivity, 72%). The corresponding specificity was 95%. The fuzzy classificator significantly improved the sensitivity of the tumor marker panel in stages I and IIIa for non-small-cell lung cancer, as well as in "limited disease" status for small-cell lung cancer. Also, the diagnosis of other stages of lung cancer was enhanced.
CONCLUSION: Fuzzy-logic analysis was proven to be more powerful than the measurement of single markers alone or combinations using multiple logistic regression analysis of all markers. Therefore, fuzzy logic offers a promising diagnostic tool to improve tumor marker efficiency.
Authors:
Joachim Schneider; Norman Bitterlich; Hans-Georg Velcovsky; Harald Morr; Norbert Katz; Erich Eigenbrodt
Related Documents :
17410025 - Primary lung cancer presenting with gastrointestinal tract involvement: clinicopatholog...
15613665 - Familial risk of lung carcinoma in the icelandic population.
10386425 - Metachronous pulmonary and oesophageal neoplasia.
24977455 - Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with...
10498395 - Prognosis in women with a carcinoma in situ of the breast: a population-based study in ...
21673825 - Synchronous parotid and thyroid gland metastases from breast cancer.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of clinical oncology     Volume:  7     ISSN:  1341-9625     ISO Abbreviation:  Int. J. Clin. Oncol.     Publication Date:  2002 Jun 
Date Detail:
Created Date:  2002-07-11     Completed Date:  2002-12-19     Revised Date:  2012-12-13    
Medline Journal Info:
Nlm Unique ID:  9616295     Medline TA:  Int J Clin Oncol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  145-51     Citation Subset:  IM    
Affiliation:
Institut und Poliklinik für Arbeits- und Socialmedizin der Justus-Liebig Universität, Giessen, Germany. Joachim.Schneider@arbmed.med.uni-giessen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Carcinoma, Non-Small-Cell Lung / diagnosis*
Carcinoma, Small Cell / diagnosis*
Case-Control Studies
Female
Fuzzy Logic*
Humans
Lung Neoplasms / diagnosis*
Male
Middle Aged
ROC Curve
Reproducibility of Results
Sensitivity and Specificity
Tumor Markers, Biological / analysis*
Chemical
Reg. No./Substance:
0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Control of cell proliferation kinetics of tumor in neoadjuvant chemotherapy for advanced oral squamo...
Next Document:  Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-sm...